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Abstract Tourette syndrome (TS) is a frequent neuropsy-
chiatric disorder of unknown etiology. A number of
chromosomal regions have been nominated as TS loci in
linkage studies, but confirmation has met with limited
success and causative mutations have not yet been
definitely identified. Furthermore, TS, chronic tics, and
obsessive–compulsive disorder (OCD) occur at increased
frequencies among TS relatives, supporting the view that
these phenotypes represent parts of the same genetically
determined spectrum. We ascertained a four-generation
Italian kindred segregating TS, chronic multiple motor tics
(CMT), and OCD, and we performed a ten-centimorgan
(cM) genome-wide linkage scan in order to map the
underlying genetic defect. Suggestive linkage to chromo-
some 14q31.1 (multipoint LOD=2.4) was detected by
affected-only analysis under an autosomal dominant model
and a narrower phenotype definition (only the subjects with
TS and CMT were considered as affected). The linkage
peak increased and it approached genome-wide significance
(LOD=3.29) when a broader phenotype definition was
adopted (subjects with TS, CMT, and OCD considered as
affected). Haplotype analysis defined a ∼2.3 cM critical
region, shared by all the relatives with TS, CMT, or OCD.
In conclusion, we provide strong evidence for linkage of TS
spectrum to chromosome 14q31.1. Suggestive linkage to an
overlapping region of chromosome 14q was reported in a
recent scan of TS sibling pairs. This region might therefore
contain an important gene for TS, and it should be
prioritized for further study.
Keywords Tourette syndrome.Tics.Movement
disorders.Linkage mapping.Locus
Introduction
Tourette syndrome (TS) is a frequent childhood-onset
neuropsychiatric disorder, characterized by multiple motor
and vocal tics that wax and wane [1]. Patients with TS
frequently develop other psychiatric disorders, such as
obsessive–compulsive disorder (OCD) and attention-deficit
hyperactivity disorder. Furthermore, TS, chronic tics, and
OCD occur at increased frequencies among relatives of TS
patients, supporting the view that these phenotypes repre-
sent parts of the same disease spectrum [2–4].
The cause of TS is unknown, but segregation analyses in
families and twin studies have consistently indicated a
strong genetic basis (reviewed in [5]). Most segregation
analyses in TS families found evidence for autosomal
dominant transmission [6–8], but other studies concluded
for a more complex inheritance [9–12]. Studies of TS cases
carrying rare chromosomal translocations led to the
identification of candidate genes, most recently SLITRK1
[13–16]. However, subsequent studies failed to convinc-
ingly replicate these findings; the involvement of the
SLITRK1 gene also remains controversial (reviewed in [5]).
In the past few years, a number of chromosomal regions
have been nominated as TS loci in linkage studies [17–23],
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causing mutations have not yet been identified, under-
scoring the complexity of TS genetics. Of note, linkage was
detected in different chromosomal regions in most studies,
suggesting the presence of substantial locus heterogeneity
in this disorder. Here, we report linkage of TS spectrum to
chromosome 14q31.1 in an Italian pedigree. Our data,
together with results of a previous study [23], suggest that
this region might contain an important gene for TS.
Subjects and methods
Thirty subjects (23 family members and seven spouses)
belonging to an Italian kindred (Fig. 1) participated in the
study after written informed consent was given and
approval was obtained from the relevant ethic authorities.
Detailed clinical studies, diagnostic workup, and exclusion
of involvement of the SLITRK1 gene in this family were
described previously [24, 25]. A diagnosis of definite TS,
definite chronic multiple motor tics (CMT), or definite non-
specific tic disorder (NST) was established in several
family members according to the criteria of the Tourette
Syndrome Classification Study Group [1]. The OCD
diagnosis was made by two psychiatrists, using the
Structured Clinical Interview for DSM and the Yale–Brown
Obsessive Compulsive Scale (Y-BOCS) [26]. An autosomal
dominant mode of inheritance was supported by one
instance of father-to-son transmission of the tics phenotype
(subject III-10 to IV-14 in Fig. 1). A high prevalence of
OCD in this family was also highlighted [24, 25]. Of note,
since the publication of our previous reports [24, 25], the
diagnosis was refined in two individuals during clinical
follow-up: in the individual IV-14 a definite TS was
diagnosed (he had previously NTS + OCD); in the
individual IV-13 the previous diagnosis of CMT was
removed due to insufficient evidence of tics at our personal
examination and unreliable historical information.
DNA was isolated from blood using standard methods.
For the linkage study, 382 short tandem repeat (STR)
markers, defining a ten-centimorgan (cM) resolution auto-
somal map, were tested from the ABI Prism Linkage
Mapping Set Version 2 (Applied Biosystems, Foster City,
CA, USA). Markers were amplified using standard poly-
merase chain reaction (PCR) methods and loaded on an
ABI 3100 automated sequencer. Data were analyzed using
Gene Mapper Version 2.1 software (Applied Biosystems).
Additional markers for fine mapping were selected from the
UCSC Human Genome Browser (http://genome.ucsc.edu/
cgi-bin/hgGateway) or newly developed by us as described
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Fig. 1 Pedigree and haplotype analysis of the chromosome 14 locus.
Square and round symbols indicate males and females, respectively.
Slashed symbols indicate deceased persons. The gender of some
individuals in the youngest generation has been disguised. Full black
symbols, TS + OCD; half symbols filled in black, CMT; upper right
quarter filled, OCD; lower left quarter filled, NTS. Empty symbols,
unaffected person. Haplotypes are shown below the individual
symbols. The disease-linked haplotype is depicted in black.Adot
within individual symbols indicates the non-manifesting carriers of the
disease-linked haplotype. Recombination events that define the
borders of the critical region are indicated by arrows
418 Neurogenetics (2010) 11:417–423elsewhere [27]. In order to optimally exploit the informa-
tion content in the initial genome-wide linkage scan, all the
markers with missing genotypes were re-typed until
complete genotype data were available for all the individ-
uals with TS or CMT.
Multi-point linkage analysis was performed using
Allegro v1.2c [28] and easyLINKAGE Plus v5.02 [29]a s
graphical interface. Affected-only linkage analysis was
carried out assuming equal recombination rates for males
and females, equal allele frequencies (estimated from the
observed genotypes), a disease allele frequency of 0.0004,
and no phenocopies. One married-in subject (III-5 in Fig. 1)
and her two children (IV-7 and IV-8) were also affected by
CMT or TS, but they were set as “unknown phenotype” in
all the linkage analyses.
In the genome-wide scan, a conservative, narrower
clinical model was adopted with only the individuals with
TS or CMT considered as “affected”. Using this model, our
linkage simulations using the program FastSLink V2.51
[30, 31] showed that the family had enough power to detect
suggestive evidence of linkage (maximum possible two-
point LOD score, 2.1; average LODs 1.4 and 1.1 at
recombination fraction 0.0 and 0.1 cM). For locus-specific
analysis of the identified region on chromosome 14q31.1,
we also used a broader clinical model, in which the subjects
with TS, CMT, and also those with OCD were considered
as “affected”.
Haplotype analyses were performed manually or using
HaploPainter V.027beta [32]. Primer sequences from the
newly developed STR markers and their location on the
human genome reference sequence (NCBI Build 37.1) are
summarized in the Online Resource 1.
For the mutation analysis of positional candidate genes,
we sequenced all coding and non-coding exons and at least
50 bases of flanking intronic sequence. Primers sequences
and PCR protocols are available from the authors. Direct
sequencing of both strands was performed using Big Dye
Terminator chemistry ver.3.1 (Applied Biosystems). Frag-
ments were loaded on an ABI3130XL automated sequencer
and analyzed with DNA Sequencing Analysis (ver.5.3) and
SeqScape (ver.2.6) software (Applied Biosystems). In order
to screen for gene copy number aberrations, two affected
individuals (IV-14, V-3) were typed on Affymetrix
GeneChip Human Mapping 250 K Nsp Arrays. Data were
analyzed using Affymetrix Genotyping Console and Nexus
Copy Number Professional V4.0 (BioDiscovery, El
Segundo, CA, USA).
Results
The results of the genome-wide affected-only multi-point
linkage analysis are presented in Fig. 2. This analysis was
performed under a conservative, narrower clinical model
(only subjects with TS or CMT considered as “affected”).
Interesting LOD scores (>1) were observed in three regions,
on chromosome 4 (markers D4S424–D4S415), on chromo-
some 14 (markers D14S276–D14S280), and on chromo-
some 21 (pter-D21S1914). Increasing the phenocopy rate
up to 0.05 did not change these results significantly (data
pLOD
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22
2.00
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Fig. 2 Genome-wide linkage results. Genome-wide plot showing the multipoint LOD scores obtained in the affected-only analysis and
considering only the subjects with TS or CMT as affected
Neurogenetics (2010) 11:417–423 419not shown). These three regions were fine mapped by
typing additional known and newly developed STR
markers, and haplotype analysis was performed. The region
on chromosome 4 was shared by all but one of the subjects
(III-6, a CMT case) considered as affected in the linkage
analysis (Online Resource 2). Thus, unless this person is a
phenocopy, this region does not contain the genetic defect
underlying the TS spectrum in this family. Also, we cannot
exclude that this region contains a modifier of the
phenotype severity. The region on chromosome 21 was
not shared by one TS and two of the CMT subjects,
considered as affected (Online Resource 3), and was
therefore also excluded from further study.
On the contrary, the analysis of the chromosome 14
region revealed a haplotype of ∼2.3 cM shared by all the
relatives with TS or CMT, considered as affected in the
linkage analysis (Fig. 1). Only the married-in subject with
CMT (III-5) and her two children with TS (IV-7, IV-8) did
not share the haplotype (these subjects are boxed in Fig. 1).
Recombination events occurring in the individual III-10
proximally and in the individuals IV-14, IV-3, and V-3
distally define the borders of the region, flanked by the
markers CGR435 and D14S1035. When the STR markers
typed for fine mapping of the chromosome 14 region were
included in the linkage analysis, a maximum multipoint
LOD score of 2.4 was obtained under the narrower clinical
model (TS and CMT as affected) (Fig. 3a), while under a
broader clinical model (TS, CMT, and also OCD as
affected) the maximum LOD score increased to 3.29
(Fig. 3b). Of note, all the subjects with only OCD also
shared the linked haplotype (Fig. 1).
The chromosome 14q critical region corresponds to
∼2.9 Mb on the physical map (NCBI human genome build
37.1) and harbors six protein-coding genes: DIO2,
C14ORF145, TSHR, GTF2A1, STON2, and SEL1L, and
one gene for a small nucleolar RNA, SNORA79. For all
these genes, we sequenced all the exons and exon–intron
boundaries, but novel variants that segregated with the
disease status were not detected (Online Resource 4).
Lastly, the analysis of the Affymetrix GeneChip Human
Mapping 250 K Nsp Arrays did not detect gene copy
number aberrations on chromosome 14q31.1 in the two
tested subjects (V-3, IV-14).
Discussion
We describe linkage to chromosome 14q31.1 in an Italian
family segregating a broad phenotypic spectrum ranging
from typical TS to CMT and OCD. Linkage studies of TS
might be complicated by a number of factors. The current
uncertainties about the exact inheritance model, the
definition of phenotype, and its relationships to other tics
and psychiatric disorders (OCD and attention deficit
hyperactivity disorders) might led to wrong clinical and
genetic model specification in linkage analyses. Due to the
high population frequency of TS and assortative mating,
phenocopies might be an important issue, especially in very
large families with multiple affected members. Further-
more, incomplete penetrance is likely present on the basis
of segregation analyses, and locus heterogeneity has been
suggested by previous linkage studies.
In order to avoid the effect of possible incomplete
penetrance, we performed an affected-only analysis includ-
ing only the subjects with TS or CMT as affected. This
conservative model yielded suggestive linkage only to
chromosome 14q31.1, with LOD scores very close to the
maximum predicted by simulations, for a family of this
size. Of note, interesting linkage peaks in other genomic
regions were not detected. However, linkage to another
region could have escaped detection because of reduced
informativity of one or more microsatellite markers.
Since there is compelling evidence from previous
genetic epidemiological and linkage studies that TS,
CMT, and also OCD might represent different clinical
expressions of the same disorder, we explored the effect of
adopting a broader phenotype definition that includes also
OCD. The linkage peak on chromosome 14 increased and
now was very close to the threshold for significant linkage
in primary genome-wide scans according to standard
criteria [33]. Furthermore, the disease-linked haplotype
was shared not only by all subjects with TS and CMT but
also by all those with OCD (Fig. 1).
In keeping with reduced penetrance of the underlying
mutation, individuals III-1 and IV-3 (Fig. 1) are non-
manifesting obligate carriers of the disease-linked haplo-
type. Seven unaffected offsprings are still at risk of
developing the disorder (IV-9, IV-10, IV-11, IV-12, IV-13,
V-4, and V-5), and four of these carry the disease-linked
haplotype (IV-10, IV-11, IV-13, and V-5). Of note, all of
these four were described by their relatives with a “very
nervous personality”, as opposed to none of the three non-
carrier offsprings. Follow-up might tell whether these
observations are coincidental or they point to mild, earlier
features of the TS spectrum disorder.
The largest genetic study of TS reported so far analyzed
238 nuclear families containing 304 affected sibling pairs
(ASP) and 18 multigenerational families [23]. Considering
only the subjects with TS as affected, the strongest
evidence for linkage was found in a region on chromosome
2p. However, the linkage signal to the same region
increased when the subjects with CMT were also included
as affected [23]. The same study detected suggestive
linkage to a few additional loci, in keeping with different
genes being involved in different groups of families.
Interestingly, out of the only three peaks with NPLpairs
420 Neurogenetics (2010) 11:417–423score >2.5 detected in the ASP genome-wide analysis, the
highest was on chromosome 14q, and again this result was
obtained either when TS subjects only or when TS and
CMT were considered as affected [23]. Linkage peaks
detected in ASP studies usually spread over large
chromosomal segments and they lack exact borders.
However, the marker yielding the maximum LOD score
in our study (D14S1000) is only ∼10 Mb and ∼13 cM
from the marker yielding the maximum LOD score in the
ASP study (D14S280). Our region lies therefore under
the linkage peak of the ASP study, and the two studies
might indeed have identified the same genetic locus.
The ∼2.3-cM interval detected in our study corresponds
to a ∼2.9-Mb region on the 14q31.1 physical map (NCBI
3.00
2.42
1.83
1.25
0.67
0.08
pLOD
cM
D
1
4
S
1
0
0
8
C
G
R
4
3
5
C
G
R
4
3
6
D
1
4
S
1
0
0
0
D
1
4
S
6
0
6
C
G
R
4
2
5
D
1
4
S
1
0
3
5
D
1
4
S
1
0
6
3
4.00
3.13
2.25
1.38
0.50
pLOD
cM
D
1
4
S
1
0
0
8
C
G
R
4
3
5
C
G
R
4
3
6
D
1
4
S
1
0
0
0
D
1
4
S
6
0
6
C
G
R
4
2
5
D
1
4
S
1
0
3
5
D
1
4
S
1
0
6
3
b
a
Fig. 3 Linkage analysis of the chromosome 14 locus. Multipoint affected-only analysis performed after fine mapping. The genetic position of the
markers is indicated on the X-axis. a Narrower phenotypic definition (TS + CMT as affected). b Broader phenotypic definition (TS + CMT +
OCD as affected)
Neurogenetics (2010) 11:417–423 421genome build 37.1). This region contains, besides seven
pseudogenes, six protein-coding genes and one gene for a
small nucleolar RNA. STON2 encodes an AP-2-dependent
endocytic sorting adaptor for synaptotagmin internalization
and recycling, suggesting involvement in neurotransmitter
release at the synapse [34]; C14ORF145 is a gene of
unknown function, that is, mainly expressed in thymus but
also in brain, spinal cortex, cerebellum, and retina;
GTFII2A1 encodes the general transcription factor IIA, a
component of the transcription machinery of RNA poly-
merase II, and plays an important role in transcriptional
activation [35]; DIO2 encodes the protein responsible for
the deiodination of T4 (thyroxine) into T3 (triiodothyro-
nine), essential for providing the brain with appropriate
levels of T3 during the critical period of development [36];
TSHR encodes the receptor of the thyroid-stimulating
hormone [37]; SEL1L encodes a protein involved in
ubiquitin-dependent endoplasmic reticulum-associated
protein degradation; SNORA79 (RNA, H/ACA box79)
encodes for a small RNA molecule involved in a variety
of processes such as gene transcription and RNA splicing.
Among these, STON2 appears to be the strongest
candidate for TS based on function and expression pattern.
Mutations in DIO2 and TSHR are associated with Graves’
disease of the thyroid [38, 39], and therefore these two
genes seem less likely candidates for TS.
We sequenced the coding regions of all these genes,
but mutations were not identified. Also, evidence of
copy number aberrations was not found by the analysis
of the SNP arrays. One possible explanation is that a
more complex and unusual type of genetic defect
underlies TS in this family. A large insertion, inversion,
or another complex chromosomal rearrangement might
be present that is not detectable by the sequencing and
copy number assays performed. It is also possible that
the mutation-causing TS is present in a non-coding
region (such as promoters and other regulatory intronic
elements), which were not sequenced in this study.
Furthermore, regulatory DNA elements might be located
far away from the target gene(s) [40]. Mutations within
linkage regions might therefore affect the regulation of
genes located outside the borders of the critical region. In
this perspective, it is worth mentioning that a very
interesting candidate gene, NRXN3, maps just outside
our linkage region. This gene helps to specify and
stabilize synapses and provides receptors for neuroligins,
neurexophilins, dystroglycans, and alpha-latrotoxins and
is also associated with addiction [41]. One possibility is
that a regulatory element for NRXN3 resides in the 2.9-Mb
linkage region, and it might be affected by a disease-
causing mutation in this family.
We acknowledge that the family size is the main limitation
of our study. Our linkage analysis under a more conservative
clinicalmodel(TS+CMT)hadenoughpowerfordetectionof
linkage at only a suggestive level. However, our results
might represent genuine linkage, because linkage signals
in other genomic regions were not detected; LOD scores
close to genome-wide significance (3.29) were achieved
using the broader clinical model (TS + CMT + OCD),
and a disease-linked haplotype was shared by all subjects
with TS, CMT, and OCD. Importantly, our results also
represent independent confirmation of the suggestive
linkage to chromosome 14q reported in the recent ASP
study [23]. Our mutation analysis performed so far should
be considered as a first step, and further screening is
warranted. The implementation of the new DNA sequencing
technologies of massively parallel sequencing [42]w i l lb e
crucial for a complete scanning of this chromosomal region
and might facilitate the detection of the genetic defect
underlying TS in this locus.
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